The peaks of HA and HHL standard eluted out of C18 column were showed in Figure S1A ,B, respectively. The negative control peak of borate buffer was showed in Figure S1 and the positive control of Captopril demonstrated a significant ACE inhibitory ratio of 86.43% at a concentration of 2 × 10 −8 mol·L −1 ( Figure 1D ). The HA concentration of the CGH ( Figure 1E ) sharply decreased compared with the negative control. 
The peaks of HA and HHL standard eluted out of C18 column were showed in Figure S1A ,B, respectively. The negative control peak of borate buffer was showed in Figure S1 and the positive control of Captopril demonstrated a significant ACE inhibitory ratio of 86.43% at a concentration of 2 × 10 −8 mol·L −1 ( Figure 1D ). The HA concentration of the CGH ( Figure 1E ) sharply decreased compared with the negative control. Figure S3 . The ACE inhibitory activity of fractions separated by GFC. Different letters above the column indicated the percentage of ACE-inhibitory activity were significantly different (p < 0.05). Figure S4 . The ESI-MS/MS spectrum of VGQLGGAAGGAF.
The ACE Inhibitory Activity of Fractions F1-F5

Sequence Profile of the Peptides VGQLGGAAGGAF
The ACE Inhibitory Activity of Fractions F5-1-F5-9 Table S1 . ACE inhibition rate of sub-fractions separated by RP-HPLC.
Fractions ACE Inhibitory Rate (%)
F5-1 42.14 ± 0. The final sample concentration was 0.01 mg·mL −1 . The data were expressed as mean ± standard deviation (n = 3). Different letters (the superscript words a-g) indicated above the percentage of ACE inhibitory activity were significantly different (p < 0.05).
